Biotecnica develops peptones ‘significantly less costly’ than ultrafiltered equivalents 28-Oct-2021 By Jane Byrne Biotecnica has launched a new line of low endotoxin peptones that do not require ultrafiltration.
New addition to DFE Pharma excipients portfolio aids in stabilizing biologics 18-May-2021 By Jane Byrne Excipient producer, DFE Pharma, is expanding its reach, capitalizing on increasing growth in the biologics sector, and launching a new sucrose stabilizer.